The new COVID test will be accompanied by a free smartphone app that will allow a user to display their test results at schools and workplaces.

The Food and Drug Administration says Abbott's BinaxNOW test and Quidel's QuickVue can be sold without a prescription. FDA Authorizes 2 Rapid, At-Home Coronavirus Tests Imagine waking up, brushing ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

July 17 (Reuters) - Abbott (ABT.N), opens new tab warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, ...

The U.S. Food and Drug Administration has issued an emergency use authorization for a new novel coronavirus test from Abbott Laboratories. Results from the speedy test come back in as little as five ...

Abbott stock jumped Wednesday despite a mixed first-quarter report thanks to light sales of its Covid tests. Sales at Abbott Laboratories' other segments, though, "were modestly better than the ...

CNN — Abbott Labs got emergency approval from the US Food and Drug Administration for its rapid antigen test, which can detect a Covid-19 infection in 15 minutes. The test is a "game changer," ...

Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...